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The mitochondrial chaperonin system consists of chaperonin 60 (also termed hsp60), which is homologous to E. coli groEL, and chaperonin 10, 
which is homologous to E. coli groES. In yeast, chaperonin 60 function has been shown to be essential for viability. We report here that the same 
is true for chaperonin 10. We have cloned, sequenced and disrupted the nuclear chaperonin 10 gene CPNIO from Succharomyces cerevisiue. This 
gene encodes a protein of 11,372 Da that is imported into the mitochondrial matrix without detectable cleavage. Haploid cells lacking a functional 
copy of CPNIO fail to grow at temperatures between 23 and 37% 
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1. INTRODUCTION 
Protein folding in bacteria, mitochondria and chloro- 
plasts is assisted by a chaperonin system that consists 
of two components [l-5]. Chaperonin 60 (cpn60; 
termed groEL in Escherichia coli, Rubisco binding pro- 
tein in chloroplasts, and hsp60 in mitochondria) is a 
homo-oligomer of 60 kDa subunits organized into two 
stacked heptameric rings. Chaperonin 10 (cpnl0; 
termed groES in E. colz] is a homo-oligomer consisting 
of 10 kDa subunits in E. coli and mitochondria, and 24 
kDa subunits in chloroplasts. The E. coli protein forms 
a single heptameric ring. In E. coli, cpn60 and cpnl0 are 
required for growth at temperatures as low as 17°C [6]. 
hsp60 is essential for viability of yeast cells [lo]. Re- 
cently we identified the cpnl0 protein of yeast mito- 
chondria, established its role in the in vitro release of an 
unfolded polypeptide from chaperonin 60, purified it as 
a complex together with chaperonin 60, and determined 
its partial amino acid sequence [l I], Here we have used 
this sequence information to clone the nuclear CPNlO 
gene from yeast, and to show that haploid cells lacking 
a functional copy of this gene are inviable at tempera- 
tures between 23 and 37°C. 
2. MATERIALS AND METHODS 
The mechanism by which cpn60 and cpnl0 mediate 
protein folding is still poorly understood. It is generally 
agreed that cpn60 binds incompletely folded polypep- 
tide chains, thereby suppressing their aggregation. The 
bound chains can then be released in a folding-compe- 
tent form by addition of cpnl0, potassium ions and 
ATP. According to this model, cpn60 traps folding in- 
termediates, and cpnl0 mediates their release. However, 
this picture may be over-simplified, as release of some 
folding intermediates from cpn60 can occur in the ab- 
sence of cpnl0 [7,8]. Thus the function and general 
importance of cpnl0 are still unclear. 
2.1. Strains and plasmids 
The E. coli strain UT580 was used for plasmid constructions. Dis- 
ruption of the CPNIO gene was performed in the diploid S. cerevisiae 
strain JK9-3d (ura3, trpl, Zeu2, hi@ [12]. Culture, transformation, and 
sporulation methods were as described [13-161. Succhuromyces cere- 
visiue was grown on YPD medium or, where appropriate, SD minimal 
medium supplemented with the required amino acids. 
2.2. Cloning and disruption of CPNlO 
The in vivo role of a protein can be readily tested in 
yeast, as nuclear genes can be specifically inactivated by 
disruption or deletion [9]. This approach has shown that 
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The CPNIO gene was cloned from yeast chromosomal DNA [ 171 by 
the polymerase chain reaction (PCR) [18], using two degenerate prim- 
ers that were designed from the partial amino acid sequence of yeast 
cpnl0 [ll]. The size of the amplytied PCR fragment corresponded to 
that predicted from comparisons with the sequences of homologous 
genes from other organisms. The purified PCR fragment was labeled 
with 3zP and used to screen the yeast genomic DNA library, R 1 S18A 
[19]. Several independent clones were identified and the region of the 
insert corresponding to CPNZO was sequenced [20]. Disruption of 
CPNIO was performed after subcloning the gene by PCR into the pCR 
II cloning vector (Invitrogen Corp.). The sequence of this PCR prod- 
uct was identical to that of the genomic clone. The plasmid used for 
disruption of CPNIO was constructed by inserting the LEU2 gene into 
the SmaI site of CPNIO (Fig. 1). For transformation of S. cerevisiue, 
the modified CPNIO gene was excised using the flanking XbaI and 
&a111 sites within the genomic DNA (Fig. 1). Diploid leu’ transfor- 
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mants were checked for disruption of the CPNIO gene by Southern 
blotting [15]. 
2.3. In vitro transcription-translation f CPNIO 
A fragment containing the coding region of CPNIO (Fig. 1) was 
ligated into the plasmid pSP65 (Promega). This construction placed 
the CPNIO gene under control of the SP6 promoter. Import of in 
vitro-synthesized cpnl0 into yeast mitochondria, protease treatment, 
and preparation of mitoplasts were as described [21,22]. Electrophore- 
sis was performed by Tricine SDS-PAGE [23]. 
3. RESULTS 
The yeast CPNlO gene encodes a protein of 106 
amino acids with a calculated mass of 11,372 Da (Fig. 
1). Like mammalian cpnl0 proteins [2,4], yeast cpnl0 
is basic, with a predicted p1 of 9.8. In contrast, groES 
from E. coli is acidic, with a p1 of 5.2 [24]. The amino 
acid sequence of yeast cpnl0 shows significant identity 
with cpnl0 proteins from bacteria and from mamma- 
lian mitochondria (Fig. 2). 
cpnl0 should be located in the mitochondrial matrix, 
as it interacts with the matrix-localized chaperonin 60 
[l 11. Indeed, the predicted N-terminal portion of yeast 
cpnl0 has the potential to form a positively charged 
a-helix, and thus resembles a typical matrix-targeting 
signal. cpnl0 proteins from rat and bovine mitochon- 
dria have N-terminal portions with similar structural 
properties [25] (Fig. 2), whereas bacterial cpnl0 proteins 
ma1 
Fig. 1. Nucleotide sequence of the CPNIO gene and deduced amino 
acid sequence of the encoded protein. Restriction sites used for cloning 









Fig. 2. Comparison of the amino acid sequences of cpnl0 from yeast 
mitochondria, rat mitochondria (Rattus norvegicus [25]), bovine mito- 
chondria @OS taurus; S.J. Pilkington and J.E. Walker, GenBank ac- 
cession no. X69556), and the procaryotes E. coli [28] and Coxiella 
burnettii [29]. Boldfaced residues are conserved or conservative in all 
five sequences. 
lack this feature (Fig. 2). Moreover, in vitro-synthesized 
radiolabeled cpnl0 is imported by isolated yeast mito- 
chondria (Fig. 3). Import is inhibited by dissipating the 
electrochemical potential across the mitochondrial 
inner membrane (Fig. 3). Protease treatment of mito- 
plasts (mitochondria in which the outer membrane has 
been selectively disrupted) confirms that cpnl0 is im- 
ported into the matrix (Fig. 3). Unlike most other ma- 
trix-targeted proteins, cpnl0 does not undergo detecta- 
ble proteolytic processing upon import. 
To study the function of yeast cpnl0, we disrupted 
one of the two chromosomal copies of the CPNlO gene 
in a diploid strain. Southern blotting confirmed that the 
transformants contained both a wild-type copy and a 
disrupted copy of CPNlO (Fig. 4A). The diploid cells 
were then sporulated, the resulting tetrads were dis- 
sected, and spores were allowed to germinate at 23, 30 
and 37°C. At all of these temperatures, only two spores 
from each tetrad formed visible colonies (Fig. 4B). 
Spores carrying the disrupted CPNlO gene germinated 
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Fig. 3. In vitro-synthesized radiolabeled cpnl0 is imported into the 
mitochondrial matrix. Import was for 10 min at 25°C. In two control 
samples, the membrane potential was dissipated by including 25 PM 
carbonyl cyanide p-tritluoromethoxyphenylhydrazone (FCCP) in the 
import mixture. Where indicated, the mitochondria (M) were treated 
after import with 0.1 mg/ml proteinase K for 30 min on ice. An 
additional sample was converted to mitoplasts (MP) in the presence 
of 0.1 mg/ml proteinase K. All samples were precipitated with 5% 
trichloroacetic acid and subjected to SDS-PAGE and fluorography. 
Efficiency of mitoplast generation and intactness of the inner mem- 
brane of mitoplasts were checked by immunoblotting of a portion of 
each sample, using antibodies against cc-ketoglutarate d hydrogenase 
(KDH; matrix marker) and cytochrome b2 (cyt. b,; inter-membrane 
space marker). The amount of marker proteins present in mitochon- 
dria after import without proteinase K treatment was taken as 100%. 
STD: 20% of the amount of labeled cpnl0 added to each sample. 
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Fig. 4. (A) Southern blot of the diploid transformants (lane 1) and of 
the wild-type yeast strain (lane 2), using the coding region of CPNlO 
as a probe. Cells transformed with the disrupted gene showed an 
additional band that was about 2 kb larger than the band from the 
undisrupted CPhVU gene. (B) Sporuiation of the heterozygous diploid 
strain and dissection of the spores yielded two viable and two non- 
viable spores; all viable spores were leucine-requiring and thus carried 
the wild-type CPiWO gene. Letters on top indicate individual tetrads 
that were dissected. 
and underwent about 4-7 cell divisions, but then 
stopped growing. The number of cell divisions de- 
creased with increasing temperature, perhaps reflecting 
the involvement of cpnl0 in a temperature-induced 
stress response [4]. Preliminary results suggest hat yeast 
cells con~i~ng a disrupted CP~~~ gene may be viable 
at 18°C. At normal growth temperatures, however, 
cpnl0 is essential for the viability of yeast cells. 
4. DISCUSSION 
~itochond~a contain hundreds of different proteins, 
most of which are dispensable for yeast growth. cpnl0 
is the latest addition to a small group of mitochondrial 
proteins the deletion or inactivation of which is lethal 
under conditions optimal for growth of wild-type cells, 
These proteins include ISP4~MOM38, mitochondrial 
hsp70, ISP45/MIM~, MAS6~IMl7, MIM23, hsp60, 
and the two subunits of the matrix processing protease 
[26,27]. All of these proteins are components of the 
machinery that mediates import, processing and folding 
of nuclear-encoded mitochondrial proteins. The availa- 
bility of the CPAVU gene should help to define the role 
of cpnl0 in ~tochond~al biogenesis. 
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